Jack Hsu, M.D.

Jack W Hsu, M.D. - Research & Publications

(352) 733-0972

Request an Appointment

Publications

A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patients
Blood Advances
2019

Poor Peripheral Blood Stem Cell Mobilization Affects Long-Term Outcomes in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Journal of Clinical Apheresis
2018

Pharmacokinetic and clinical outcomes when ideal body weight is used to dose busulfan in obese hematopoietic stem cell transplant recipients.
Bone Marrow Transplantation
2018

Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia
Blood Advances
2018

Efficacy of Micafungin for the Treatment of Invasive Candidiasis and Candidaemia in Patients With Neutropenia
Mycoses
2018

Minimal Residual Disease By Either Flow Cytometry or Cytogenetics Prior to An Allogeneic Hematopoietic Stem Cell Transplant Is Associated With Poor Outcome in Acute Myeloid Leukemia
Blood Cancer Journal
2017

Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia

2017

A Rare Case of Raoultella Planticola Urinary Tract Infection in An Immunocompromised Patient With Multiple Myeloma
Idcases
2017

Metabolic Syndrome and Cardiovascular Disease After Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations From the Cibmtr and Ebmt

2016

Effect of Melphalan 140 Mg/M(2) Vs 200 Mg/M(2) on Toxicities and Outcomes in Multiple Myeloma Patients Undergoing Single Autologous Stem Cell Transplantation-a Single Center Experience
Clinical Transplantation
2016

Autologous Hematopoietic Cell Transplantation for Hiv-Related Lymphoma: Results of the Bmt Ctn 0803/Amc 071 Trial
Blood
2016

A New Model to Predict Remission Status in Aml Patients Based on Day 14 Bone Marrow Biopsy
Leukemia Research
2016

Uric Acid and the Prediction Models of Tumor Lysis Syndrome in Aml
PLOS One
2015

Race and Ethnicity Influences Collection of Granulocyte Colony-Stimulating Factor-Mobilized Peripheral Blood Progenitor Cells From Unrelated Donors, a Center for International Blood and Marrow Transplant Research Analysis

2015

Poor Peripheral Blood Stem Cell Mobilization Correlates With Worse Long-Term Outcomes in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

2015

Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502
Journal of Clinical Oncology
2015

Long-Term Survival and Late Effects Among One-Year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic Syndromes

2015

Tacrolimus/Sirolimus Vs Tacrolimus/Methotrexate as Gvhd Prophylaxis After Matched, Related Donor Allogeneic Hct
Blood
2014

Second Solid Cancers After Allogeneic Hematopoietic Cell Transplantation Using Reduced-Intensity Conditioning

2014

Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma
Biology of Blood and Marrow Transplantation
2014

Outcomes of Human Leukocyte Antigen-Matched Sibling Donor Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia: Myeloablative Versus Reduced-Intensity Conditioning Regimens

2014

Hematopoietic Stem-Cell Transplantation for Advanced Systemic Mastocytosis
Journal of Clinical Oncology
2014

Elevated Incidence of Chronic Myeloid Leukaemia in Immunosuppressed Solid Organ Transplant Recipients
British Journal of Haematology
2014

Does Total Body Irradiation Conditioning Improve Outcomes of Myeloablative Human Leukocyte Antigen-Identical Sibling Transplantations for Chronic Lymphocytic Leukemia?

2014

Avascular Necrosis of Bone After Allogeneic Hematopoietic Cell Transplantation in Children and Adolescents

2014

Allotransplantation for patients age ≥40 years with non-Hodgkin lymphoma: encouraging progression-free survival
Biology of Blood and Marrow Transplantation
2014

Alk1 as a Novel Therapeutic Target for Cd30(+) T-Anaplastic Large Cell Lymphoma

2014

The Role of Monoclonal Antibodies in the Treatment of Lymphomas
Expert Opinion on Biological Therapy
2013

Impact of Pretransplantation Conditioning Regimens On Outcomes of Allogeneic Transplantation for Chemotherapy-Unresponsive Diffuse Large B Cell Lymphoma and Grade III Follicular Lymphoma

2013

Hematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin Lymphoma
Journal of Clinical Oncology
2013

Autologous and Allogeneic Transplantation for Burkitt Lymphoma Outcomes and Changes in Utilization: a Report From the Center for International Blood and Marrow Transplant Research

2013

Association of Mannose Binding Lectin (Mbl) Levels and Invasive Fungal Disease (Ifd) in Hematologic Malignancy Patients Undergoing Hematopoietic Stem Cell Transplantation (Hsct) Or Receiving Chemotherapy

2013

Allogeneic Hematopoietic Cell Transplantation for Chemotherapy-Unresponsive Mantle Cell Lymphoma: a Cohort Analysis From the Center for International Blood and Marrow Transplant Research

2013

Response Post-First Autologous Stem Cell Transplantation for Multiple Myeloma May Identify Patients Who Will Benefit From Tandem Transplants: a Single Center Prospective Phase II Study- An Update
Blood
2012

Quality of Life, Social Challenges, and Psychosocial Support for Long-Term Survivors After Allogeneic Hematopoietic Stem-Cell Transplantation
Seminars in Hematology
2012

Peripheral Blood Cd34(+) Specific Donor Chimerism Analysis as An Early Indicator of Disease Relapse After Allogeneic Hematopoietic Stem Cell Transplant in Patients With Myelodysplastic Syndromes and Acute Myelogenous Leukemia.
Blood
2012

Late Effects in Hematopoietic Cell Transplant Recipients With Acquired Severe Aplastic Anemia: a Report From the Late Effects Working Committee of the Center for International Blood and Marrow Transplant Research

2012

Higher Than Expected Incidence of Chronic Myeloid Leukemia in Solid Organ Transplant Recipients.
Blood
2012

Alternate Donor Hematopoietic Cell Transplantation (Hct) in Non-Hodgkin Lymphoma Using Lower Intensity Conditioning: a Report From the Cibmtr

2012

A Phase II Study of Allogeneic Transplantation for Older Patients With Aml in First Complete Remission Using a Reduced Intensity Conditioning Regimen: Results From Calgb 100103/Bmt Ctn 0502
Blood
2012

A Phase I Study of the Vascular Disrupting Combretastatin, Oxi4503, in Patients With Relapsed and Refractory Acute Myeloid Leukemia (Aml) and Myelodysplastic Syndromes (Mds)
Blood
2012

Hematopoietic Stem Cell Transplantation: An Overview of Infection Risks and Epidemiology
Hematology/Oncology Clinics of North America
2011

Comparison of Short-Term Response and Long-Term Outcomes After Initial Systemic Treatment of Chronic Graft-Versus-Host Disease

2011

Hypomethylating agent induction therapy followed by hematopoietic cell transplantation is feasible in patients with myelodysplastic syndromes.
Clinical Advances in Hematology and Oncology
2010

Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology.
Infectious Disease Clinics of North America
2010

Phase II Study of Bryostatin 1 and Vincristine for Aggressive Non-Hodgkin Lymphoma Relapsing After An Autologous Stem Cell Transplant
American Journal of Hematology
2009

Non-Myeloablative Allogeneic Stem Cell Transplantation To Treat High Risk Heavily Pretreated Multiple

2008

Research Interests

  • Dr. Hsu focuses on training and instruction of residents and fellows in the Bone Marrow Transplant Unit and the Hematological Malignancy service. He participates in teaching conferences for housestaff and division fellows, and is also an active participant in cooperative group trials in leukemia, lymphoma and transplantation.

Active Research Studies